Sign Up to like & get
recommendations!
0
Published in 2022 at "Environmental and Molecular Mutagenesis"
DOI: 10.1002/em.22472
Abstract: Urologic cancers involve nearly one‐quarter of all cancers and include the prostate, bladder, and kidney cancers. Long non‐coding RNAs (LncRNAs) are expressed in a tissue‐specific manner and affect cell proliferation, apoptosis, and differentiation. LncRNAs expression…
read more here.
Keywords:
urologic cancers;
urologic cancer;
cancer risk;
lncrna polymorphisms ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "European urology"
DOI: 10.1016/j.eururo.2017.12.018
Abstract: The Tumor-Node-Metastasis (TNM) classification on cancer staging, jointly developed by the American Joint Commission on Cancer (AJCC) and the Union for International Cancer Control (UICC), has been updated to its 8th edition with two contemporaneous…
read more here.
Keywords:
urologic cancers;
node metastasis;
classification;
tumor node ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000000775
Abstract: PURPOSE OF REVIEW Systemic treatment of advanced urogenital malignancies has changed significantly in recent years and it will continue to change rapidly in upcoming years. It is the scope of this review article to providing…
read more here.
Keywords:
advanced urologic;
urologic cancers;
therapy;
therapies advanced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer Management and Research"
DOI: 10.2147/cmar.s178271
Abstract: Background Emerging studies reported that preoperative albumin-to-globulin ratio (AGR) correlated with tumor progression and prognosis in several types of cancer. The aim of this study was to systematically explore the association between preoperative AGR and…
read more here.
Keywords:
albumin globulin;
urologic cancers;
preoperative albumin;
globulin ratio ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15020546
Abstract: Urologic cancers, particularly kidney, bladder, and prostate cancer, have a growing incidence and account for about a million annual deaths worldwide. Treatments, including surgery, chemotherapy, radiotherapy, hormone therapy, and immunotherapy are the main therapeutic options…
read more here.
Keywords:
immunotherapy;
combination;
urologic cancers;
urologic cancer ... See more keywords